NASDAQ:MTP
Delisted
Midatech Pharma PLC Stock News
$0.285
+0 (+0%)
At Close: Jun 23, 2023
Midatech Pharma plc 2020 Q2 - Results - Earnings Call Presentation
06:33am, Friday, 11'th Sep 2020
The following slide deck was published by Midatech Pharma plc in conjunction with their 2020 Q2 earnings call.
Midatech Pharma plc (MTP) CEO Craig Cook on Q2 2020 Results - Earnings Call Transcript
11:53am, Thursday, 10'th Sep 2020
Midatech Pharma plc (NASDAQ:MTP) Q2 2020 Earnings Conference Call Sept 10, 2020, 09:00 AM ET Company Participants Tim Sparey - Chief Business Officer Stephen Stamp - COO & CFO Conference Call Part
Midatech Pharma PLC Announces Exercise of Warrants and Issue of Equity
06:00am, Wednesday, 19'th Aug 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / August 19, 2020 / Midatech Pharma PLC (AIM:MTPH.
Midatech Pharma PLC Announces Registration Statement Declared Effective
06:00am, Friday, 14'th Aug 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / August 14, 2020 / Midatech Pharma PLC (AIM:MTPH.
Midatech Pharma PLC Announces Corporate Update & Formal Sale Process Termination
06:00am, Thursday, 23'rd Jul 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / July 23, 2020 / Midatech (AIM:MTPH.
Midatech Pharma PLC announces Publication of Annual Report
01:40pm, Tuesday, 30'th Jun 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 30, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medi
Midatech Pharma PLC Announces Grant of Options
06:00am, Wednesday, 17'th Jun 2020
ABINGDON, OXFORDSHIRE ACCESSWIRE / June, 17, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medic
Midatech Pharma PLC Announces Results for the year ended 31 December 2019
06:00am, Tuesday, 16'th Jun 2020
Preliminary results for the year ended 31 December 2019 ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 16, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused
Midatech Pharma PLC Announces Purported Termination of MTX110 Licence Agreement
03:35pm, Tuesday, 09'th Jun 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 9, 2020 / Midatech Pharma PLC (MTPH.L) (MTP) (the "Company"), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of
Midatech Pharma PLC - Rule 2.9 Announcement
10:00am, Friday, 22'nd May 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 22, 2020 / In accordance with Rule 2.9 of the Takeover Code, Midatech confirms that, as at the date of this announcement, it has 39,252,557 ordinary shares wit
Midatech Pharma PLC Announces Rule 2.9 Announcement
06:01am, Thursday, 21'st May 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2020 / In accordance with Rule 2.9 of the Takeover Code, Midatech confirms that, as at the date of this announcement, it has 32,585,891 ordinary shares wit
Midatech Pharma PLC Announces Closing of US$3.0m Registered Direct Offering
06:00am, Thursday, 21'st May 2020
ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2020 / Midatech Pharma PLC (MTPH.L)(MTP), an R&D; biotechnology company focused on delivering innovative oncology and rare disease products to patients, to
Midatech Pharma PLC - Correction: UK Placing to Raise £1.8 million
11:15am, Tuesday, 19'th May 2020
Correction: The following amendment has been made to the 'UK Placing to Raise £1.8 million' announcement released on 18 May 2020. THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION TO BUY S
